Sinclair, EmilyBSc, M.R.T.(T), DCR(T)
Emily Sinclair
Sunnybrook Health Sciences Centre
2075 Bayview Avenue
Toronto, ON M4N 3M5
Tel. (416) 480-5000 x3072
Fax (416) 480-4672
Academic Rank
Lecturer
Professional Qualifications
BSc
M.R.T.(T)
DCR(T), Anglia University, UK
Appointments
Lecturer, Department of Radiation Oncology, University of Toronto
Palliative care Radiation Therapist, Research Therapist, Sunnybrook Odette Cancer Centre
Academic & Clinical Interests
- Palliative radiation therapy
- Ethical considerations for palliative patients
- Quality of life for palliative patients
Current Research Projects
- Symptoms, quality of life and management of patients with brain metastases seen in the RRRP
- Assessing quality of life in cancer patients receiving palliative radiotherapy for symptomatic lung cancer or lung metastases using the European Organization for Research and Treatment of Cancer Lung Cancer Module (EORTC QLQ-LC13)
- SC-20U- Effect of Re-Irradiation for bone pain on Urinary Markers of Osteoclast Activity –A companion study to SC 20
- SC-20 – A Phase III International Randomized Trial of Single Versus Multiple Fractions for Re-irradiation of painful bone metastases
- NCIC Clinical Trials Group
- Examining the incidence of pain flare following external beam radiotherapy in the treatment of bone metastases
- Canadian-led International Validation of the European Organization for Research and Treatment of Cancer Brain Module (EORTC QLQ-BN20) for Assessing Quality of Life in Patients with Brain Metastases
- Prospective Analysis of Antiemetic Medication Prescribed for Radiation Induced Emesis for Patients seen in the Rapid Response Radiotherapy Program (RRRP)
- Shortening of the European Organization for Research and Treatment of Cancer Bone Metastases Module
- Effect of Radiation for Bone Metastases in Patients with Prostate Cancer on Urinary Markers of Osteoclast Activity
- A Prospective cohort study of androgen independent prostate cancer patients receiving zoledronic acid
- Effectiveness of Palliative Radiotherapy in the treatment of bone metastases employing the Brief Pain Inventory
- Development of a Canadian-led international bone metastases module to accompany the European Organization for Research and Treatment of Cancer Quality of Life Group core questionnaire (EORTC QLQ-C30) for future clinical trials in patients with bone metastases
- Dexamethasone for the prophylaxis of radiation-induced pain flare following palliative radiotherapy for bone metastases: A Phase II study
- Multi-lingual Validation of the EORTC QLQ-BM22
- Developing a user-generated approach to health outcome measurement for older patients with cancer: pilot testing and validation of a questionnaire